|
G |
Top2a |
DNA topoisomerase II alpha |
decreases activity |
ISO |
altenusin results in decreased activity of TOP2A protein |
CTD |
PMID:27682608 |
|
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
|
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
multiple interactions |
ISO |
solabegron binds to and results in increased activity of ADRB3 protein |
CTD |
PMID:18651730 |
|
NCBI chr16:69,003,541...69,006,632
Ensembl chr16:69,003,868...69,006,632
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity multiple interactions |
ISO |
telmisartan results in decreased activity of ABCB11 protein telmisartan inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:20829430 PMID:23956101 PMID:24014644 |
|
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
multiple interactions increases expression |
ISO |
PPARG mutant form inhibits the reaction [telmisartan results in increased expression of ABCG1 mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr20:9,743,269...9,842,735
Ensembl chr20:9,743,269...9,840,489
|
|
G |
Ace |
angiotensin I converting enzyme |
decreases expression multiple interactions |
EXP |
Telmisartan results in decreased expression of ACE mRNA; Telmisartan results in decreased expression of ACE protein Telmisartan inhibits the reaction [Pregabalin results in increased expression of ACE protein] |
CTD |
PMID:19171132 PMID:25973029 PMID:29909460 PMID:31629013 |
|
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
multiple interactions decreases expression increases expression |
ISO EXP |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of ACE2 protein] Telmisartan inhibits the reaction [Pregabalin results in decreased expression of ACE2 protein] Telmisartan results in decreased expression of ACE2 mRNA; Telmisartan results in decreased expression of ACE2 protein Telmisartan results in increased expression of ACE2 mRNA; Telmisartan results in increased expression of ACE2 protein |
CTD |
PMID:21381899 PMID:25973029 PMID:28656296 PMID:29909460 PMID:31629013 |
|
NCBI chr X:32,050,734...32,095,860
Ensembl chr X:32,049,931...32,096,016
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [telmisartan inhibits the reaction [Streptozocin results in increased activity of ACHE protein]]; telmisartan inhibits the reaction [Streptozocin results in increased activity of ACHE protein] |
CTD |
PMID:23060470 |
|
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
telmisartan results in increased expression of ADIPOQ mRNA telmisartan results in increased expression of ADIPOQ protein |
CTD |
PMID:19730415 PMID:20555330 |
|
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Agt |
angiotensinogen |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein] telmisartan results in decreased expression of AGT mRNA; telmisartan results in decreased expression of AGT protein Telmisartan inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA]; Telmisartan inhibits the reaction [AGT protein results in decreased expression of SYP protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; Telmisartan inhibits the reaction [AGT protein results in increased ubiquitination of SYP protein]; Telmisartan inhibits the reaction [Diatrizoate results in increased expression of AGT protein]; Telmisartan inhibits the reaction [Iohexol results in increased expression of AGT protein]; Telmisartan inhibits the reaction [Pregabalin results in decreased expression of AGT protein] |
CTD |
PMID:9533614 PMID:17620961 PMID:18487452 PMID:19171132 PMID:19289654 PMID:19292980 PMID:19452295 PMID:19706694 PMID:31629013 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
affects binding decreases expression multiple interactions increases expression |
EXP ISO |
telmisartan binds to AGTR1 protein telmisartan results in decreased expression of AGTR1A mRNA telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA]; telmisartan inhibits the reaction [Streptozocin results in increased expression of AGTR1A protein] telmisartan binds to and results in decreased activity of AGTR1 protein Telmisartan binds to and results in decreased activity of AGTR1 protein; Telmisartan inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; Telmisartan inhibits the reaction [Daunorubicin results in increased expression of AGTR1A protein]; Telmisartan inhibits the reaction [Pregabalin results in increased expression of AGTR1 protein] telmisartan results in increased expression of AGTR1 mRNA |
CTD |
PMID:8220885 PMID:9533614 PMID:9728324 PMID:17620961 PMID:19171132 PMID:19706694 PMID:20888384 PMID:21381899 PMID:21557540 PMID:31629013 |
|
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Agtr1b |
angiotensin II receptor, type 1b |
multiple interactions |
ISO |
telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:17620961 |
|
NCBI chr 2:105,149,020...105,224,335
Ensembl chr 2:105,149,020...105,224,295
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases activity |
EXP |
Telmisartan results in increased activity of AHR protein |
CTD |
PMID:28728110 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Alb |
albumin |
affects expression |
ISO |
telmisartan affects the expression of ALB protein modified form |
CTD |
PMID:16671338 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Ang2 |
angiogenin, ribonuclease A family, member 2 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of ANG2 protein] |
CTD |
PMID:23750309 |
|
NCBI chr15:28,103,688...28,121,494
Ensembl chr15:28,103,703...28,104,206
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX mRNA] |
CTD |
PMID:24831514 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA] |
CTD |
PMID:24831514 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BDNF mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BDNF protein] |
CTD |
PMID:23747572 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions decreases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA]; SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA] |
CTD |
PMID:19292980 |
|
NCBI chr10:82,129,071...82,197,828
Ensembl chr10:82,129,506...82,197,848
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
multiple interactions decreases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA]; SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA] |
CTD |
PMID:19292980 |
|
NCBI chr10:14,730,932...14,789,201
Ensembl chr10:14,730,941...14,788,617
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP3 protein] Telmisartan results in decreased expression of CASP3 protein Telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; Telmisartan inhibits the reaction [Diatrizoate results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [Iohexol results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of CASP3]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of and results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP3 mRNA] telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] |
CTD |
PMID:18565324 PMID:19452295 PMID:21620867 PMID:21819444 PMID:22750630 PMID:24831514 PMID:26439596 PMID:29909460 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Telmisartan inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] |
CTD |
PMID:23750309 PMID:26929000 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] telmisartan results in decreased expression of CCL2 protein |
CTD |
PMID:17922026 PMID:22124178 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
decreases response to substance |
ISO |
telmisartan results in decreased susceptibility to CCL5 protein |
CTD |
PMID:18158351 |
|
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
decreases expression |
EXP |
telmisartan results in decreased expression of CCR2 mRNA |
CTD |
PMID:17922026 |
|
|
|
G |
Cd36 |
CD36 molecule |
increases expression multiple interactions |
ISO |
telmisartan results in increased expression of CD36 mRNA PPARG mutant form inhibits the reaction [telmisartan results in increased expression of CD36 mRNA]; T 0070907 inhibits the reaction [telmisartan results in increased expression of CD36 mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
EXP |
telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]] |
CTD |
PMID:19289654 |
|
NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
|
|
G |
Crp |
C-reactive protein |
decreases expression |
ISO |
telmisartan results in decreased expression of CRP protein |
CTD |
PMID:20555330 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
multiple interactions decreases response to substance |
ISO |
PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]]; telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein] telmisartan results in decreased susceptibility to CXCL12 protein |
CTD |
PMID:18158351 |
|
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression multiple interactions |
ISO EXP |
telmisartan results in decreased expression of CYBA mRNA; telmisartan results in decreased expression of CYBA protein telmisartan inhibits the reaction [Daunorubicin results in increased expression of CYBA protein] |
CTD |
PMID:16141465 PMID:19171132 PMID:21054405 |
|
NCBI chr19:55,249,634...55,257,824
Ensembl chr19:55,249,616...55,257,876
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Streptozocin results in increased expression of CYBB protein] telmisartan results in decreased expression of CYBB mRNA |
CTD |
PMID:19171132 PMID:21381899 |
|
NCBI chr X:14,578,330...14,610,049
Ensembl chr X:14,578,264...14,612,547
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CYCS mRNA] |
CTD |
PMID:24831514 |
|
NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
decreases activity |
ISO |
Telmisartan results in decreased activity of CYP2J2 protein |
CTD |
PMID:30965050 |
|
NCBI chr 5:119,546,458...119,564,843
Ensembl chr 5:119,546,461...119,564,846
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
decreases expression |
EXP |
telmisartan results in decreased expression of DDIT3 protein |
CTD |
PMID:19102871 |
|
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDN1 protein] |
CTD |
PMID:20888384 |
|
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDNRA protein] |
CTD |
PMID:20888384 |
|
NCBI chr19:33,928,356...33,991,703
Ensembl chr19:33,928,356...33,991,703
|
|
G |
Ednrb |
endothelin receptor type B |
multiple interactions |
EXP |
telmisartan promotes the reaction [Daunorubicin results in increased expression of EDNRB protein] |
CTD |
PMID:20888384 |
|
NCBI chr15:88,004,775...88,036,354
Ensembl chr15:88,006,977...88,036,354
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO EXP |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASL protein] telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASLG protein] |
CTD |
PMID:21620867 PMID:21819444 |
|
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 protein] |
CTD |
PMID:19706694 |
|
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF mRNA]; Telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF protein] |
CTD |
PMID:23747572 |
|
NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein] Telmisartan results in decreased expression of GFAP protein |
CTD |
PMID:23747572 PMID:29909460 |
|
NCBI chr10:90,990,762...90,999,435
Ensembl chr10:90,990,762...90,999,506
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of GGT1 protein] |
CTD |
PMID:23750309 |
|
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein] |
CTD |
PMID:26929000 |
|
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
|
|
G |
Hgf |
hepatocyte growth factor |
increases expression |
ISO |
telmisartan results in increased expression of HGF mRNA |
CTD |
PMID:21479465 |
|
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
EXP |
telmisartan results in decreased expression of HSPA5 protein |
CTD |
PMID:19102871 |
|
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO EXP |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] telmisartan inhibits the reaction [Daunorubicin results in increased expression of ICAM1 protein] telmisartan inhibits the reaction [Streptozocin results in increased expression of ICAM1 mRNA] |
CTD |
PMID:17724226 PMID:20888384 PMID:22124178 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Il10 |
interleukin 10 |
multiple interactions increases expression |
EXP |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein] Telmisartan results in increased expression of IL10 protein |
CTD |
PMID:24831514 PMID:29909460 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] Telmisartan results in decreased expression of IL6 protein telmisartan results in decreased expression of IL6 mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein]; telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein] telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein] |
CTD |
PMID:19289654 PMID:21479465 PMID:22124178 PMID:29909460 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Ins2 |
insulin 2 |
decreases expression |
ISO |
telmisartan results in decreased expression of INS protein |
CTD |
PMID:15892894 |
|
NCBI chr 1:215,856,967...215,858,034
Ensembl chr 1:215,856,971...215,858,034
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of IRAK1 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr X:156,716,469...156,726,367
Ensembl chr X:156,716,604...156,725,977
|
|
G |
Lipe |
lipase E, hormone sensitive type |
multiple interactions increases expression |
ISO |
PPARD promotes the reaction [telmisartan results in increased expression of LIPE protein] |
CTD |
PMID:20176998 |
|
NCBI chr 1:82,248,031...82,266,727
Ensembl chr 1:82,248,046...82,266,727
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:22124178 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions decreases phosphorylation |
ISO EXP |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] telmisartan results in decreased phosphorylation of MAPK14 protein |
CTD |
PMID:19292980 PMID:22124178 |
|
NCBI chr20:5,933,290...5,995,137
Ensembl chr20:5,933,303...5,995,137
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:22124178 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of MAPKAPK2 protein modified form] |
CTD |
PMID:21381899 |
|
NCBI chr13:47,785,157...47,871,684
Ensembl chr13:47,785,161...47,831,110
|
|
G |
Mas1 |
MAS1 proto-oncogene, G protein-coupled receptor |
multiple interactions increases expression |
ISO EXP |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of MAS1 protein] Telmisartan inhibits the reaction [Pregabalin results in decreased expression of MAS1 protein] Telmisartan results in increased expression of MAS1 protein |
CTD |
PMID:21381899 PMID:28656296 PMID:31629013 |
|
NCBI chr 1:48,076,761...48,108,218
Ensembl chr 1:48,077,033...48,108,216
|
|
G |
Mir146a |
microRNA 146a |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of MIR146A |
CTD |
PMID:20524934 |
|
NCBI chr10:28,962,476...28,962,570
Ensembl chr10:28,962,476...28,962,570
|
|
G |
Mir146b |
microRNA 146b |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of MIR146B |
CTD |
PMID:20524934 |
|
NCBI chr 1:266,089,488...266,089,575
Ensembl chr 1:266,089,488...266,089,575
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
EXP |
telmisartan results in decreased expression of MMP2 protein |
CTD |
PMID:21054405 |
|
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO EXP |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [telmisartan inhibits the reaction [Streptozocin results in increased activity of MPO protein]]; telmisartan inhibits the reaction [Streptozocin results in increased activity of MPO protein] Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased activity of MPO protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased activity of MPO protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] |
CTD |
PMID:23060470 PMID:24831514 PMID:26439596 PMID:26929000 |
|
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Streptozocin results in increased expression of NCF1 protein] telmisartan inhibits the reaction [Daunorubicin results in increased expression of NCF1 protein] Telmisartan results in decreased expression of NCF1 mRNA; Telmisartan results in decreased expression of NCF1 protein telmisartan results in decreased expression of NCF1 mRNA; telmisartan results in decreased expression of NCF1 protein |
CTD |
PMID:16141465 PMID:19171132 PMID:21054405 PMID:21381899 |
|
NCBI chr12:25,497,104...25,506,300
Ensembl chr12:25,497,104...25,506,300
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Streptozocin results in increased expression of NCF2 protein] telmisartan results in decreased expression of NCF2 mRNA; telmisartan results in decreased expression of NCF2 protein telmisartan inhibits the reaction [Daunorubicin results in increased expression of NCF2 protein] |
CTD |
PMID:16141465 PMID:21054405 PMID:21381899 |
|
NCBI chr13:70,226,441...70,259,019
Ensembl chr13:70,226,647...70,257,576
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NFKB1 protein] |
CTD |
PMID:21620867 |
|
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of NOS2 protein] telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 protein]; telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of NOS2]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA] |
CTD |
PMID:21620867 PMID:21819444 PMID:22750630 PMID:24831514 PMID:26439596 PMID:26929000 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions increases phosphorylation increases expression |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in increased expression of NOS3 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in increased phosphorylation of NOS3 protein] |
CTD |
PMID:21156825 |
|
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of NOX4 protein] |
CTD |
PMID:21054405 |
|
NCBI chr 1:150,796,359...150,976,186
Ensembl chr 1:150,797,084...150,976,194
|
|
G |
Nppb |
natriuretic peptide B |
affects expression multiple interactions decreases expression |
ISO EXP |
telmisartan affects the expression of NPPB protein Telmisartan inhibits the reaction [Pregabalin results in increased expression of NPPB protein] telmisartan results in decreased expression of NPPB protein |
CTD |
PMID:16671338 PMID:18712048 PMID:31629013 |
|
NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 mRNA]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 protein] |
CTD |
PMID:22124178 |
|
NCBI chr 4:163,239,853...163,261,937
Ensembl chr 4:163,239,849...163,261,958
|
|
G |
Plau |
plasminogen activator, urokinase |
multiple interactions |
EXP |
telmisartan inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
increases expression multiple interactions |
EXP ISO |
telmisartan results in increased expression of PPARD protein PPARD promotes the reaction [telmisartan results in increased expression of LIPE protein]; PPARD promotes the reaction [telmisartan results in increased expression of UCP1 protein]; PPARD promotes the reaction [telmisartan results in increased expression of UCP2 protein]; PPARD promotes the reaction [telmisartan results in increased expression of UCP3 protein] |
CTD |
PMID:20176998 |
|
NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression increases activity |
ISO EXP |
PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]; PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; PPARG mutant form inhibits the reaction [telmisartan results in increased expression of ABCG1 mRNA]; PPARG mutant form inhibits the reaction [telmisartan results in increased expression of CD36 mRNA]; PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]] telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] telmisartan results in increased expression of PPARG protein telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] Telmisartan results in increased activity of PPARG protein |
CTD |
PMID:18158351 PMID:20176998 PMID:20888384 PMID:21381899 PMID:22124178 PMID:24831514 PMID:28728110 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARGC1A protein] |
CTD |
PMID:21381899 |
|
NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
multiple interactions |
EXP |
Telmisartan inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] |
CTD |
PMID:31629013 |
|
NCBI chr19:25,095,089...25,118,869
Ensembl chr19:25,095,089...25,118,860
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO EXP |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] telmisartan inhibits the reaction [sodium arsenite results in increased expression of PTGS2 protein] [Telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [Daunorubicin results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of PTGS2]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] |
CTD |
PMID:20223228 PMID:20888384 PMID:22124178 PMID:22750630 PMID:24831514 PMID:26439596 PMID:26929000 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Pth1r |
parathyroid hormone 1 receptor |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of PTH1R protein] |
CTD |
PMID:23750309 |
|
NCBI chr 8:118,984,531...119,012,803
Ensembl chr 8:118,988,053...119,012,671
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of PTHLH protein] |
CTD |
PMID:23750309 |
|
NCBI chr 4:181,663,425...181,674,181
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP ISO |
[telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of RELA protein]; telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of RELA protein]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA mRNA]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA protein] telmisartan inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein] |
CTD |
PMID:20223228 PMID:22124178 PMID:24831514 PMID:26929000 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Ren |
renin |
increases expression |
EXP |
telmisartan results in increased expression of REN mRNA; telmisartan results in increased expression of REN protein |
CTD |
PMID:9533614 |
|
NCBI chr13:50,502,724...50,513,953
Ensembl chr13:50,502,724...50,514,151
|
|
G |
Scn5a |
sodium voltage-gated channel alpha subunit 5 |
increases activity |
ISO |
telmisartan results in increased activity of SCN5A protein |
CTD |
PMID:29306026 |
|
NCBI chr 8:128,169,191...128,266,681
Ensembl chr 8:128,169,191...128,266,639
|
|
G |
Sema3b |
semaphorin 3B |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Calcitriol results in increased expression of SEMA3B protein]; telmisartan inhibits the reaction [Progesterone results in increased expression of SEMA3B protein] |
CTD |
PMID:21933904 |
|
NCBI chr 8:116,353,791...116,362,655
Ensembl chr 8:116,354,073...116,361,343
|
|
G |
Sema3f |
semaphorin 3F |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Calcitriol results in increased expression of SEMA3F protein]; telmisartan inhibits the reaction [Progesterone results in increased expression of SEMA3F protein] |
CTD |
PMID:21933904 |
|
NCBI chr 8:116,439,996...116,469,915
Ensembl chr 8:116,437,696...116,469,915
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
ISO EXP |
telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA]; telmisartan inhibits the reaction [Hydrogen Peroxide results in increased expression of SERPINE1 mRNA] telmisartan inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:17620961 PMID:19706694 |
|
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Slc18a2 |
solute carrier family 18 member A2 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC18A2 protein] |
CTD |
PMID:23747572 |
|
NCBI chr 1:280,397,831...280,457,968
Ensembl chr 1:280,423,079...280,457,148
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 protein] |
CTD |
PMID:23747572 |
|
NCBI chr 1:32,323,011...32,363,983
Ensembl chr 1:32,321,580...32,363,983
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SNCA mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SNCA protein] |
CTD |
PMID:23747572 |
|
NCBI chr 4:90,782,412...90,883,236
Ensembl chr 4:90,782,374...90,882,285
|
|
G |
Syp |
synaptophysin |
multiple interactions |
ISO EXP |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of SYP protein] telmisartan inhibits the reaction [AGT protein results in decreased expression of SYP protein]; telmisartan inhibits the reaction [AGT protein results in increased ubiquitination of SYP protein] |
CTD |
PMID:18487452 |
|
NCBI chr X:15,694,699...15,709,244
Ensembl chr X:15,695,566...15,707,436
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein] telmisartan results in decreased expression of TGFB1 mRNA telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; telmisartan inhibits the reaction [Daunorubicin results in increased expression of TGFB1 protein] |
CTD |
PMID:19171132 PMID:19706694 PMID:20888384 PMID:21381899 |
|
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein] |
CTD |
PMID:23747572 |
|
NCBI chr 1:216,073,034...216,080,287
Ensembl chr 1:216,073,031...216,080,287
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions decreases expression affects localization |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan affects the localization of TJP1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in decreased expression of TJP1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in decreased expression of TJP1 protein]; wortmannin inhibits the reaction [telmisartan affects the localization of TJP1 protein]; wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 mRNA]; wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 protein] telmisartan results in decreased expression of TJP1 mRNA; telmisartan results in decreased expression of TJP1 protein |
CTD |
PMID:19252288 |
|
NCBI chr 1:126,146,489...126,515,359
Ensembl chr 1:126,146,489...126,227,469
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of TLR4 mRNA; [Atorvastatin co-treated with Telmisartan] results in decreased expression of TLR4 protein |
CTD |
PMID:20524934 |
|
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO EXP |
PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; T 0070907 inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; T 0070907 inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Telmisartan results in decreased expression of TNF protein telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of TNF protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of TNF protein]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein] 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; [telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of TNF protein]; telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of TNF]; telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of TNF]; telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein] |
CTD |
PMID:19289654 PMID:20223228 PMID:21620867 PMID:21819444 PMID:22124178 PMID:22750630 PMID:24831514 PMID:26439596 PMID:26929000 PMID:29909460 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of TRAF6 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr 3:91,252,829...91,271,607
Ensembl chr 3:91,252,829...91,271,607
|
|
G |
Ucp1 |
uncoupling protein 1 |
multiple interactions increases expression |
ISO |
PPARD promotes the reaction [telmisartan results in increased expression of UCP1 protein] |
CTD |
PMID:20176998 |
|
NCBI chr19:24,456,976...24,464,808
Ensembl chr19:24,456,976...24,464,807
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions increases expression |
ISO |
PPARD promotes the reaction [telmisartan results in increased expression of UCP2 protein] |
CTD |
PMID:20176998 |
|
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
|
|
G |
Ucp3 |
uncoupling protein 3 |
multiple interactions increases expression |
ISO |
PPARD promotes the reaction [telmisartan results in increased expression of UCP3 protein] |
CTD |
PMID:20176998 |
|
NCBI chr 1:165,482,912...165,495,895
Ensembl chr 1:165,482,155...165,496,206
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of VCAM1 protein] |
CTD |
PMID:20888384 |
|
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Streptozocin results in increased expression of VEGFA mRNA] telmisartan inhibits the reaction [sodium arsenite results in increased expression of VEGFA] telmisartan results in decreased expression of VEGFA mRNA |
CTD |
PMID:17724226 PMID:19171132 PMID:26439596 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|